Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$2.5MFederal grants as PI5 awards
1Patents grantedLatest Dec 1, 2020
65Papers2,221 citations
Federal awards and patents by year
AwardsPatents
5 awards · $2.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 20, 2018 | NIH | SBIR Phase I Biologic Inhibitor of Galectin-3 for Liver Fibrosis | $300K | MANDALMED, INC. |
| Aug 17, 2018 | NIH | SBIR Phase II Inhibition of Galectin-3 for Therapy of Remodeling After Myocardial Infarction Supplement | $132K | MANDALMED, INC. |
| Mar 6, 2018 | NIH | SBIR Phase II Inhibition of Galectin-3 for Therapy of Remodeling After Myocardial Infarction | $1.1M | MANDALMED, INC. |
| Apr 10, 2017 | NIH | SBIR Phase II Inhibition of Galectin-3 for Therapy of Remodeling After Myocardial Infarction | $809K | MANDALMED, INC. |
| Aug 15, 2016 | NIH | SBIR Phase II Inhibition of Galectin-3 for Therapy of Remodeling After Myocardial Infarction | $225K | MANDALMED, INC. |
2 patents as inventor
- US 10851348MANDALMED, INC.Dec 1, 2020
- US MANDALMED, INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#757
Awards as PI#417
Patents#155
Companies
- MANDALMED, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.